Cargando…

Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds

BACKGROUND: Diabetes is among the strongest predictors of outcome after coronary artery stenting and the incidence of negative outcomes is still high in this specific group. Data of long-term outcomes comparing diabetic patients with non-diabetic patients treated with bioresorbable scaffolds are sti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anadol, Remzi, Schnitzler, Katharina, Lorenz, Liv, Weissner, Melissa, Ullrich, Helen, Polimeni, Alberto, Münzel, Thomas, Gori, Tommaso
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944115/ https://www.ncbi.nlm.nih.gov/pubmed/29743023 http://dx.doi.org/10.1186/s12872-018-0811-7

Ejemplares similares

Procedural Predictors for Bioresorbable Vascular Scaffold Thrombosis: Analysis of the Individual Components of the “PSP” Technique
por: Dimitriadis, Zisis, et al.
Publicado: (2019)

Five Years Outcomes and Predictors of Events in a Single-Center Cohort of Patients Treated with Bioresorbable Coronary Vascular Scaffolds
por: Anadol, Remzi, et al.
Publicado: (2020)

Long-term outcome of bioresorbable vascular scaffolds for the treatment of coronary artery disease: a meta-analysis of RCTs
por: Polimeni, Alberto, et al.
Publicado: (2017)

Incidental Finding of Strut Malapposition Is a Predictor of Late and Very Late Thrombosis in Coronary Bioresorbable Scaffolds
por: Boeder, Niklas F., et al.
Publicado: (2019)

Bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: a meta-analysis
por: Polimeni, Alberto, et al.
Publicado: (2019)

Bioresorbable vascular scaffold: a step back thinking of the future
por: Polimeni, Alberto, et al.
Publicado: (2018)

Coronary Stent Strut Fractures: Classification, Prevalence and Clinical Associations
por: Schochlow, Katharina, et al.
Publicado: (2021)

Randomised, non-inferiority, controlled procedural outcomes TrIal comParing reverse T And Protrusion versus double-kissing and crush stenting: protocol of the TIP TAP I randomised trial
por: Rakhimov, Kudrat, et al.
Publicado: (2020)

Bioresorbable scaffolds for percutaneous coronary interventions
por: Gogas, Bill D.
Publicado: (2014)

The duration of balloon inflation affects the luminal diameter of coronary segments after bioresorbable vascular scaffolds deployment
por: Sorrentino, Sabato, et al.
Publicado: (2015)

Bioresorbable scaffolds in the treatment of coronary artery disease
por: Zhang, Yaojun, et al.
Publicado: (2013)

Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results from the GABI-R Registry
por: Gori, Tommaso, et al.
Publicado: (2019)

Bioresorbable Scaffolds in Coronary Intervention: Unmet Needs and Evolution
por: Capodanno, Davide
Publicado: (2017)

In vitro and in vivo degradation of microfiber bioresorbable coronary scaffold
por: Huang, Chi‐Hung, et al.
Publicado: (2017)

Randomized, crossover, controlled trial on the modulation of cardiac coronary sinus hemodynamics to develop a new treatment for microvascular disease: Protocol of the MACCUS trial
por: Ullrich, Helen, et al.
Publicado: (2023)

Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention
por: Tenekecioglu, Erhan, et al.
Publicado: (2016)

Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB™): 2-year results from the GABI-R-registry
por: Pahmeier, Kathrin, et al.
Publicado: (2022)

QFR Predicts the Incidence of Long-Term Adverse Events in Patients with Suspected CAD: Feasibility and Reproducibility of the Method
por: Buono, Andrea, et al.
Publicado: (2020)

Bioresorbable scaffolds: everything resolved?
por: Appelman, Yolande
Publicado: (2015)

Bioresorbable Scaffolds for Atheroregression: Understanding of Transient Scaffolding
por: N. Kharlamov, M.D., Alexander
Publicado: (2016)

Three-year clinical outcomes of a sirolimus-eluting bioresorbable scaffold (XINSORB) and a metallic stent to treat coronary artery stenosis
por: Wu, Yizhe, et al.
Publicado: (2020)

Current status of clinically available bioresorbable scaffolds in percutaneous coronary interventions
por: Felix, Cordula, et al.
Publicado: (2015)

Effectiveness of additional X-ray protection devices in reducing Scattered radiation in radial interventions: protocol of the ESPRESSO randomised trial
por: Anadol, Remzi, et al.
Publicado: (2019)

Quantitative Flow Ratio or Angiography for the Assessment of Non-culprit Lesions in Acute Coronary Syndromes: Protocol of the Randomized Trial QUOMODO
por: Ullrich, Helen, et al.
Publicado: (2022)

Coronary Venous Pressure and Microvascular Hemodynamics in Patients With Microvascular Angina: A Randomized Clinical Trial
por: Ullrich, Helen, et al.
Publicado: (2023)

Bioresorbable Polymeric Scaffold in Cardiovascular Applications
por: Toong, Daniel Wee Yee, et al.
Publicado: (2020)

Bioresorbable Drug-Eluting Magnesium-Alloy Scaffold for Treatment of Coronary Artery Disease
por: Campos, Carlos M., et al.
Publicado: (2013)

Recommendations for the use of bioresorbable vascular scaffolds in percutaneous coronary interventions: 2017 revision
por: Everaert, B., et al.
Publicado: (2017)

Impact of Coronary Atherosclerosis on Bioresorbable Vascular Scaffold Resorption and Vessel Wall Integration
por: Cheng, Yanping, et al.
Publicado: (2020)

Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users: A position statement on the use of bioresorbable vascular scaffolds in the Netherlands
por: Everaert, Bert, et al.
Publicado: (2015)

Automatic segmentation of optical coherence tomography pullbacks of coronary arteries treated with bioresorbable vascular scaffolds: Application to hemodynamics modeling
por: Bologna, Marco, et al.
Publicado: (2019)

Coronary artery perforation after bioresorbable scaffold implantation treated with a new generation covered stent—OCT insights
por: Chen, D., et al.
Publicado: (2022)

Vascular restoration therapy and bioresorbable vascular scaffold
por: Wang, Yunbing, et al.
Publicado: (2014)

Bioresorbable vascular scaffolds: between promises and reality
por: Montone, Rocco A., et al.
Publicado: (2017)

In vivo degradation and endothelialization of an iron bioresorbable scaffold
por: Lin, Wenjiao, et al.
Publicado: (2020)

Bioresorbable Scaffolds: Current Technology and Future Perspectives
por: Forrestal, Brian, et al.
Publicado: (2020)

Bioresorbable Scaffolds: Contemporary Status and Future Directions
por: Peng, Xiang, et al.
Publicado: (2020)

Thrombosis and myocardial infarction: the role of bioresorbable scaffolds
por: Leesar, Massoud A., et al.
Publicado: (2023)

Bioresorbable vascular scaffold implantation in acute coronary syndromes: clinical evidence, tips and tricks
por: Giacchi, Giuseppe, et al.
Publicado: (2015)

Use of bioresorbable vascular scaffold: a meta-analysis of patients with coronary artery disease
por: Farag, Mohamed, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r73vo1an04b6t3e7pjsokur0fr